Preferable Outcome of Janus Kinase Inhibitors For a Group of Difficult-to-Treat Rheumatoid Arthritis Patients: From The FIRST Registry
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI